Esuprone

Esuprone
Names
	Preferred IUPAC name 3,4-Dimethyl-2-oxo-2H-1-benzopyran-7-yl ethanesulfonate
Identifiers
CAS Number	91406-11-0 ;
3D model (JSmol)	Interactive image;
ChEMBL	ChEMBL18504 ;
ChemSpider	59239 ;
PubChem CID	65827;
UNII	K7EB9E48ZE ;
CompTox Dashboard (EPA)	DTXSID60238549 ;
	InChI InChI=1S/C13H14O5S/c1-4-19(15,16)18-10-5-6-11-8(2)9(3)13(14)17-12(11)7-10/h5-7H,4H2,1-3H3 Key: CHDGAVDQRSPBTA-UHFFFAOYSA-N ; InChI=1/C13H14O5S/c1-4-19(15,16)18-10-5-6-11-8(2)9(3)13(14)17-12(11)7-10/h5-7H,4H2,1-3H3 Key: CHDGAVDQRSPBTA-UHFFFAOYAR;
	SMILES O=S(=O)(Oc2ccc\1c(OC(=O)/C(=C/1C)C)c2)CC;
Properties
Chemical formula	C13H14O5S
Molar mass	282.31 g·mol−1
	Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa). verify (what is ?) Infobox references

Esuprone is an experimental drug candidate being investigated as an antidepressant.^[2] It acts as a monoamine oxidase A (MAO-A) inhibitor.^[3]

References

^ Ganellin, C. R (1996). Dictionary of pharmacological agents. CRC Press. p. 1056. ISBN 978-0-412-46630-4.
^ Vértes, Attila (2003). Handbook of nuclear chemistry. Springer. p. 155. ISBN 978-1-4020-1316-4.
^ Bergström, M; Westerberg, G; Németh, G; Traut, M; Gross, G; Greger, G; Müller-Peltzer, H; Safer, A; et al. (1997). "MAO-A inhibition in brain after dosing with esuprone, moclobemide and placebo in healthy volunteers: In vivo studies with positron emission tomography". European Journal of Clinical Pharmacology. 52 (2): 121–8. doi:10.1007/s002280050260. PMID 9174681. S2CID 25359613.